Skip to main content

Table 2 Comparison of variant classifications between a subset of novel PathOS variants submitted to a commercial tertiary analysis platform showing concordance

From: Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnostics

CTAP

PathOS

Benign

Likely benign

VUS

Likely pathogenic

Pathogenic

Benign

0

0

0

0

0

Likely benign

1

0

0

0

0

VUS

1

0

248

17

29

Likely pathogenic

0

0

1

1

9

Pathogenic

0

0

0

0

0